135 related articles for article (PubMed ID: 31296434)
1. Bone Marrow-derived Mesenchymal Stem Cells and Chronic Allograft Disease in a Bronchiolitis Obliterans Animal Model.
Gómez de Antonio D; Campo-Cañaveral de la Cruz JL; Zurita M; Santos M; González Lois C; Varela de Ugarte A; Vaquero J
Arch Bronconeumol (Engl Ed); 2020 Mar; 56(3):149-156. PubMed ID: 31296434
[TBL] [Abstract][Full Text] [Related]
2. Effects of Intraperitoneal Injection of Allogeneic Bone Marrow-derived Mesenchymal Stem Cells on Bronchiolitis Obliterans in Mice Model.
Işık S; Uzuner N; Karaman M; Karaman Ö; Kıray M; Kozanoğlu İ; Alper Bağrıyanık H; Arıkan-Ayyıldız Z; Kartal Yandım M; Baran Y
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):205-218. PubMed ID: 28732434
[TBL] [Abstract][Full Text] [Related]
3. Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model.
Zhao Y; Gillen JR; Harris DA; Kron IL; Murphy MP; Lau CL
J Thorac Cardiovasc Surg; 2014 May; 147(5):1668-1677.e5. PubMed ID: 24199758
[TBL] [Abstract][Full Text] [Related]
4. LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats.
Tu ZL; Zhou ZY; Xu HC; Cao JL; Ye P; Wang LM; Lv W; Hu J
J Cardiothorac Surg; 2017 May; 12(1):43. PubMed ID: 28545478
[TBL] [Abstract][Full Text] [Related]
5. The macrolide clarithromycin inhibits experimental post-transplant bronchiolitis obliterans.
Remund K; Rechsteiner T; Guo Z; Rentsch K; Boehler A
Exp Lung Res; 2009 Dec; 35(10):830-40. PubMed ID: 19995277
[TBL] [Abstract][Full Text] [Related]
6. Heterotopic tracheal transplantation animal model of bronchiolitis obliterans: a reproducible model.
Gómez-de-Antonio D; Campo-Cañaveral de la Cruz JL; Gonzalez-Lois C; Santos M; Millán I; Varela de Ugarte A
Ann Transplant; 2013 Dec; 18():661-70. PubMed ID: 24309319
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous donor marrow cell transplantation with reduced intensity conditioning prevents tracheal allograft obliteration in a bronchiolitis obliterans murine model.
Nusair S; Or R; Junadi S; Amir G; Breuer R
Chest; 2005 Dec; 128(6):4024-9. PubMed ID: 16354876
[TBL] [Abstract][Full Text] [Related]
8. Lung transplantation in the fischer 344-wistar kyoto strain combination is a relevant experimental model to study the development of bronchiolitis obliterans in the rat.
von Süßkind-Schwendi M; Ruemmele P; Schmid C; Hirt SW; Lehle K
Exp Lung Res; 2012 Apr; 38(3):111-23. PubMed ID: 22394285
[TBL] [Abstract][Full Text] [Related]
9. Fibroblasts of recipient origin contribute to bronchiolitis obliterans in human lung transplants.
Bröcker V; Länger F; Fellous TG; Mengel M; Brittan M; Bredt M; Milde S; Welte T; Eder M; Haverich A; Alison MR; Kreipe H; Lehmann U
Am J Respir Crit Care Med; 2006 Jun; 173(11):1276-82. PubMed ID: 16528017
[TBL] [Abstract][Full Text] [Related]
10. Human adipose-derived mesenchymal stem cells alleviate obliterative bronchiolitis in a murine model via IDO.
Zheng G; Qiu G; Ge M; He J; Huang L; Chen P; Wang W; Xu Q; Hu Y; Shu Q; Xu J
Respir Res; 2017 Jun; 18(1):119. PubMed ID: 28619045
[TBL] [Abstract][Full Text] [Related]
11. Role of airway epithelial injury in murine orthotopic tracheal allograft rejection.
Kuo E; Bharat A; Shih J; Street T; Norris J; Liu W; Parks W; Walter M; Patterson GA; Mohanakumar T
Ann Thorac Surg; 2006 Oct; 82(4):1226-33. PubMed ID: 16996912
[TBL] [Abstract][Full Text] [Related]
12. A new murine model for bronchiolitis obliterans post-bone marrow transplant.
Panoskaltsis-Mortari A; Tram KV; Price AP; Wendt CH; Blazar BR
Am J Respir Crit Care Med; 2007 Oct; 176(7):713-23. PubMed ID: 17575098
[TBL] [Abstract][Full Text] [Related]
13. Are we near to an effective drug treatment for bronchiolitis obliterans?
Verleden GM; Vos R; Dupont L; Van Raemdonck DE; Vanaudenaerde BM; Verleden SE
Expert Opin Pharmacother; 2014 Oct; 15(15):2117-20. PubMed ID: 25154562
[TBL] [Abstract][Full Text] [Related]
14. Effects of azithromycin and tanomastat on experimental bronchiolitis obliterans.
Krenn K; Gmeiner M; Paulus P; Sela N; Torres L; Zins K; Dekan G; Aharinejad S
J Thorac Cardiovasc Surg; 2015 Apr; 149(4):1194-202. PubMed ID: 25595376
[TBL] [Abstract][Full Text] [Related]
15. Local origin of mesenchymal cells in a murine orthotopic lung transplantation model of bronchiolitis obliterans.
Mimura T; Walker N; Aoki Y; Manning CM; Murdock BJ; Myers JL; Lagstein A; Osterholzer JJ; Lama VN
Am J Pathol; 2015 Jun; 185(6):1564-74. PubMed ID: 25848843
[TBL] [Abstract][Full Text] [Related]
16. Impact of the severity of acute rejection in the early phase after rat lung transplantation on the effectiveness of mycophenolate mofetil to treat chronic allograft rejection.
von Suesskind-Schwendi M; Hirt SW; Diez C; Ruemmele P; Puehler T; Schmid C; Lehle K
Eur J Cardiothorac Surg; 2012 Jul; 42(1):142-8. PubMed ID: 22398468
[TBL] [Abstract][Full Text] [Related]
17. The role of epithelial-mesenchymal transition in the post-lung transplantation bronchiolitis obliterans.
Zhang C; Niu Y; Yu L; Lv W; Xu H; Abuduwufuer A; Cao J; Hu J
J Cardiothorac Surg; 2017 Dec; 12(1):119. PubMed ID: 29262833
[TBL] [Abstract][Full Text] [Related]
18. Chronic lung allograft dysfunction after lung transplantation: the moving target.
Sato M
Gen Thorac Cardiovasc Surg; 2013 Feb; 61(2):67-78. PubMed ID: 23138970
[TBL] [Abstract][Full Text] [Related]
19. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
[TBL] [Abstract][Full Text] [Related]
20. A relevant experimental model for human bronchiolitis obliterans syndrome.
Atanasova S; Hirschburger M; Jonigk D; Obert M; Petri K; Evers A; Hecker A; Schmitz J; Kaufmann A; Wilhelm J; Chakraborty T; Warnecke G; Gottlieb J; Padberg W; Grau V
J Heart Lung Transplant; 2013 Nov; 32(11):1131-9. PubMed ID: 24050896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
